CClinicalTrials.gg
Sign In
CompletedNCT02026648Updated Sep 7, 2016

Outcome of Women With Cervical Cancer

An observational study in Cervical Cancer, sponsored by Far Eastern Memorial Hospital. Completed at 1 site in Taiwan. Open to female participants aged 20 Years to 99 Years. Per ClinicalTrials.gov, last updated 2016-09-07.

Sponsored by Far Eastern Memorial Hospital · Observational

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
81
Ages
20 Years to 99 Years
Sex
Female
01

Study summary

Squamous cell carcinoma (SCC) of the cervix has showed a marked decline in developed countries over the past 40 years, however, there has also been an increase in relative and absolute incidence of adenocarcinoma and adenosquamous carcinoma (AC) of the uterine cervix over the same period.

Our understanding of the natural history and optimal management of AC is limited. It appears that AC and SCC of the cervix behave differently. They are different in epidemiology, prognostic factors, and patterns of failure after similar treatments. Available data suggest that they may also differ in their response to treatment. We postulate that new treatment strategies specifically tailored to AC should be explored.

However, there is few data about outcome of cervical cancer in Taiwan. So we propose this proposal for retrospective analysis of clinicopathological parameters and outcomes in patients of cervical cancer, especially for cervical adenocarcinoma and adenosquamous carcinoma.

02

Conditions studied

  • Cervical Cancer
03

In context

Uterine Cervical Neoplasms

1,881 studies on the registry are indexed under Uterine Cervical Neoplasms; 565 are open to participants now.

This study's enrollment of 81 is below the median of 220 across 419 observational studies indexed under Uterine Cervical Neoplasms.

Browse Uterine Cervical Neoplasms studies →

Lead sponsor

Far Eastern Memorial Hospital is the lead sponsor of 253 studies on the registry; 38 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 99 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

the cases with cervical cancer

Inclusion criteria

  • Time interval: from 1991 to date.
  • Comprehensive surgical staging, debulking procedure, radiotherapy or chemotherapy.
  • All female patients with cervical cancer who underwent treatment for cervical cancer at Far Eastern Memorial Hospital.
  • All the patients diagnosed as cervical cancer, especially for women with adeno- and adenosquamous carcinoma.

  • To review:

    1. Clinical data: including age at diagnosis, presenting symptoms, gravidity, parity, menstrual history, body mass index, history of diabetes, hypertension, personal history of cancer and staging.
    2. Pathologic information: deep stromal invasion, lymph-vascular space invasion, lymph node involvement, parametrium invasion, vaginal cut end and tumor size.
    3. Survival data: disease-free and overall survival.
    4. Radiation report, Chemotherapy treatment, operation, discharge and admission note.

Exclusion criteria

Exclusion Criteria:

  • Not comprehensive staging/debulking procedure.
  • Patients who died of postoperative complications within 30 days after surgery were excluded from the survival analysis.
  • Female minors or disabled persons.
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
81 participants (actual)
Patient registry
No

Groups and cohorts

  • cases with cervical cancer
06

What researchers measure

Primary outcomes

  1. Outcome of women with cervical cancer

    Time frame: 20 years

07

Study locations

1 site
  • Far Eastern Memorial Hospital
    Banqiao, Taipei 22050, Taiwan
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 7, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02026648
Lead sponsor
Far Eastern Memorial Hospital
Responsible party
Sheng-Mou Hsiao (Chief, Department of Obstetrics & Gynecology, Far Eastern Memorial Hospital) — Principal investigator
First posted
Jan 3, 2014
Start date
Jan 2014
Primary completion
Nov 2015
Completion
May 2016
Last update
Sep 7, 2016
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Uterine Cervical Neoplasms→

Other studies from this sponsor

Far Eastern Memorial Hospital

Start the discussion